Endocrine
[Endocrine ]
EPTIS Ringversuch Nr. 142519 | Letze Änderung 2024-12-20 | URL: https://www.eptis.bam.de/pts142519 https://www.eptis.bam.de/pts142519
| Name des Anbieters | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Name des Anbieters | Weqas Weqas | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Ansässig in | United Kingdom | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Sprache(n) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Anmerkungen | Four levels of liquid human serum samples are distributed monthly, with a minimum of 48 samples distributed over the year covering a wide clinically relevant range for steroid, thyroid function and fertility profiles. The material is prepared from endogenous samples donated by both patients and healthy volunteers, with the addition of purified source of T4, T3, TSH, oestradiol, progesterone and cortisol to enhance the pathological range for certain samples. Challenging samples are distributed to assess the performance at clinical decision points as well as effects of interferences such as turbidity, icterus, heterophilic antibodies along with an ongoing programme of interpretative exercises. Macroprolactin exercises are conducted periodically to assess current laboratory practice in Macroprolactin investigation. Key Features: ✓ Commutable, endogenous samples including those that challenge immunoassays such as sample with Macroprolactin and antibody interferences, and samples that mimic ovarian hyperstimulation syndrome. ✓ Liquid human serum samples requiring no prior preparation. ✓ Single donor samples are used wherever possible to minimise any matrix effects. Programme assesses both laboratory and method performance, including bias, within and between batch imprecision. ✓ Trueness is also assessed for Testosterone, Cortisol and Progesterone using high metrological order Reference measurement systems. ✓ Includes Calculated parameters. ✓ Scoring based on Milan Model 3 performance specification. For more information: https://www.weqas.com/services/eqa/endocrine/ or contact@weqas.com | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Klassifizierung | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Produktgruppen |
Health care / medical devices
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
| Prüfgebiete |
Medical analysis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
| Technische Einzelheiten | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ringversuchsziele | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Zielgruppe des Ringversuchs | Laboratory Diagnostic Services | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Relevante Rechtsvorschriften oder Normen | Accreditation by UKAS on the basis of ISO/IEC 17025, 17043 and 15195 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Weitere Ziele | validation of testing methods | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Teilnehmerzahl | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt) |
Akkreditiert durch UKAS auf der Grundlage von ISO/IEC 17043 |
|||||||||||||||||||||||||||||||||||||||||||||||||||
| Die Durchführung des Ringversuchs ist in Auftrag gegeben durch | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Kosten | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Teilnahmegebühr | https://www.weqas.com/participantzone/subscription-charges/ | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Regelmässig durchgeführt | Ja (Frequency: Monthly. Samples: 4 x 1.8mL) | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Der Ringversuch wird durchgeführt seit | 1968 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Kontaktdaten des Anbieters | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Anbieter | Kontaktperson | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
Weqas
Unit 6, Parc Ty Glas CF14 5DU Cardiff United Kingdom Telefon: 44 (0) 2920 314750 Fax: Web: http://www.weqas.com http://www.weqas.com |
Laura Lloyd-Lewis
Telefon: 44 (0) 29218 32884 Fax: E-Mail: laura.lloyd-lewis@wales.nhs.uk laura.lloyd-lewis@wales.nhs.uk |
|||||||||||||||||||||||||||||||||||||||||||||||||||
Haben Sie einen Fehler entdeckt? Bitte wenden Sie sich an den zuständigen EPTIS Koordinator für United Kingdom,
Mr Savvas Xystouris.
Mr Savvas Xystouris.